Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Carnitor
Generic Name
Levocarnitine
Active Ingredient
LevocarnitineCategory
Amino Acid [EPC]
Variants
3
References used for this content
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Carnitor, you must consult a qualified healthcare professional.
Detailed information about Carnitor
Levocarnitine is a naturally occurring amino acid derivative essential for energy metabolism. It is primarily used to treat carnitine deficiency in patients with metabolic disorders or end-stage renal disease.
The dosage of Levocarnitine is highly individualized and depends on the severity of the deficiency and the patient's clinical response.
Levocarnitine is approved for use in infants and children. Dosing is strictly weight-based:
Healthcare providers will monitor blood carnitine levels frequently in children to ensure the dose is supporting growth and metabolic stability without causing excessive side effects.
In patients with severe renal impairment (not on dialysis), chronic administration of high oral doses of Levocarnitine is generally avoided. This is because the metabolites (trimethylamine) can accumulate in the blood due to decreased clearance, potentially leading to increased toxicity or the characteristic fishy odor. For patients on dialysis, the IV route is preferred to bypass the gut and reduce metabolite buildup.
No specific dosage adjustments are provided in the manufacturer's labeling for patients with liver disease. However, since the liver is a site of carnitine synthesis, patients with advanced cirrhosis may have altered carnitine requirements and should be monitored closely.
Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular timing. Do not 'double up' on doses to catch up, as this increases the risk of gastrointestinal side effects.
Symptoms of a Levocarnitine overdose typically include severe diarrhea, stomach cramps, and a strong fishy body odor. While Levocarnitine is generally considered to have low acute toxicity, an overdose should be reported to a poison control center or emergency room immediately. Treatment is supportive, focusing on hydration and managing gastrointestinal distress.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop the medication without medical guidance, as this could lead to a metabolic crisis in patients with primary deficiency.
Most patients tolerate Levocarnitine well, but gastrointestinal issues are frequent, especially with oral administration.
Levocarnitine is a potent metabolic intervention and should only be used under the strict supervision of a healthcare provider, preferably one specializing in metabolic disorders or nephrology. It is not a general nutritional supplement for healthy individuals and should not be used for athletic performance enhancement without medical advice, as the risks and benefits in healthy populations differ significantly from those with clinical deficiencies.
No FDA black box warnings for Levocarnitine. Unlike many other metabolic drugs, Levocarnitine has not been associated with high-risk mortality or severe organ failure that would necessitate a boxed warning.
There are no drugs that are strictly 'contraindicated' (never to be used) with Levocarnitine in the traditional sense. However, the use of D-Carnitine (the mirror image isomer) is strictly prohibited as it acts as a competitive antagonist to Levocarnitine and can induce a deficiency state.
Levocarnitine is a normal component of human milk. Supplementation in the mother will increase the carnitine content of breast milk. While no adverse effects have been documented in nursing infants whose mothers were taking Levocarnitine, it is recommended that breastfeeding mothers consult their physician. The benefits of breastfeeding generally outweigh the risks, especially given that carnitine is essential for infant development.
Levocarnitine is the biologically active L-isomer of carnitine. Its primary molecular target is the enzyme system involved in fatty acid transport. It acts as a substrate for Carnitine Palmitoyltransferase I (CPT-I) and CPT-II. By forming an acylcarnitine complex, it allows long-chain fatty acids to bypass the impermeable inner mitochondrial membrane. This is the rate-limiting step in fatty acid oxidation. Additionally, it maintains the Acetyl-CoA/CoA ratio within the cell, which is vital for the continued operation of the Citric Acid (Krebs) Cycle.
The pharmacodynamic effect of Levocarnitine is measured by the restoration of carnitine levels in the plasma and tissues. The onset of action for metabolic stabilization can be rapid (hours in IV administration for acute toxicity), but the improvement in muscle strength or cardiac function may take weeks or months of consistent therapy. There is no evidence of tolerance development; the body continues to utilize exogenous Levocarnitine as long as the deficiency state exists.
Common questions about Carnitor
Levocarnitine is primarily used to treat and prevent carnitine deficiency, a condition where the body does not have enough of this substance to convert fats into energy. It is FDA-approved for primary carnitine deficiency, which is a genetic disorder, and secondary carnitine deficiency, often seen in patients with end-stage renal disease undergoing hemodialysis. By restoring carnitine levels, the medication helps improve heart and muscle function and prevents the buildup of toxic metabolic byproducts. Your doctor may also prescribe it off-label for certain types of drug toxicity, such as that caused by valproic acid. It is an essential therapy for those whose bodies cannot produce or retain enough carnitine naturally.
The most frequently reported side effects of Levocarnitine are gastrointestinal in nature, including nausea, vomiting, stomach cramps, and diarrhea. These symptoms are usually mild and can often be managed by taking the medication with food or by consuming the oral solution slowly throughout the day. A unique and common side effect is a 'fishy' body odor, which occurs because bacteria in the gut break down unabsorbed carnitine into a gas called trimethylamine. This odor can sometimes be reduced by adjusting the dose or taking Vitamin B2 (riboflavin) under medical supervision. Other less common effects include headache, dizziness, and a slight increase in blood pressure. Most side effects are dose-dependent and improve if the dosage is lowered.
While there is no known direct chemical interaction between Levocarnitine and alcohol, it is generally advisable to limit alcohol consumption. Alcohol can stress the liver and kidneys, which are the organs responsible for carnitine synthesis and excretion, potentially complicating the management of your underlying condition. Furthermore, alcohol can cause dehydration and electrolyte imbalances, which may worsen the side effects of Levocarnitine, such as dizziness or nausea. If you have a metabolic disorder or kidney disease, your body's ability to process alcohol is already compromised. Always discuss your lifestyle habits, including alcohol use, with your healthcare provider to ensure the safest treatment outcome. They can provide personalized guidance based on the specific reason you are taking Levocarnitine.
Levocarnitine is classified as FDA Pregnancy Category B, meaning that animal studies have not shown harm to the fetus, but there are limited well-controlled studies in pregnant women. However, because Levocarnitine is a naturally occurring substance and is vital for fetal energy metabolism, it is often continued during pregnancy if the mother has a confirmed deficiency. Untreated carnitine deficiency during pregnancy can lead to serious complications for both the mother and the baby, including heart problems and low blood sugar. Most specialists believe the benefits of maintaining normal carnitine levels outweigh the potential risks of the medication. If you are pregnant or planning to become pregnant, your doctor will monitor your blood levels closely to ensure the dose is appropriate for your changing metabolic needs. Never start or stop this medication during pregnancy without expert medical advice.
The time it takes for Levocarnitine to work depends on the condition being treated and the symptoms you are experiencing. For acute metabolic issues or drug toxicity, intravenous Levocarnitine can begin to stabilize the body's chemistry within a few hours. However, for chronic conditions like muscle weakness or cardiomyopathy related to carnitine deficiency, it may take several weeks or even months of consistent use to notice a significant improvement. Blood tests will typically show an increase in carnitine levels within the first week of therapy, but physical symptoms take longer to resolve as tissues slowly accumulate the necessary carnitine. Your healthcare provider will use regular blood work to confirm the medication is working at the cellular level. Patience and adherence to the prescribed schedule are key to seeing the full benefits of the treatment.
You should never stop taking Levocarnitine suddenly, especially if you are taking it for a primary genetic deficiency. Sudden discontinuation can cause your carnitine levels to plummet, which may trigger a metabolic crisis characterized by severe exhaustion, muscle breakdown (rhabdomyolysis), and dangerous drops in blood sugar. For patients with heart conditions related to deficiency, stopping the drug could lead to acute heart failure or arrhythmias. If you are experiencing bothersome side effects, contact your doctor to discuss a supervised dose reduction rather than stopping the medication entirely. Your healthcare provider will develop a safe plan if the medication ever needs to be discontinued. Consistent levels are necessary to maintain the 'carnitine shuttle' that keeps your cells fueled.
If you miss a dose of Levocarnitine, take it as soon as you remember to maintain consistent levels in your body. However, if it is almost time for your next scheduled dose, you should skip the missed dose and simply take your next one at the regular time. Do not take two doses at once to make up for the missed one, as this significantly increases the likelihood of experiencing gastrointestinal side effects like diarrhea and nausea. Keeping a consistent schedule is important for managing metabolic disorders effectively. If you find yourself frequently forgetting doses, consider using a pill organizer or setting a daily alarm. If you miss several doses in a row, notify your healthcare provider, as they may want to check your blood levels.
Levocarnitine is not typically associated with significant weight gain. In fact, because it plays a central role in fat metabolism, some research has explored its use in weight loss, though it is not FDA-approved for that purpose and is generally ineffective for weight loss in people with normal carnitine levels. Some patients might experience slight changes in weight as their overall metabolic health improves and their energy levels increase, which may lead to changes in appetite or activity levels. If you notice rapid or unexplained weight gain while taking this medication, it is more likely related to other factors, such as fluid retention in patients with kidney or heart disease. Always report significant weight changes to your doctor. They can help determine if the change is related to your medication or your underlying health condition.
Levocarnitine can be taken with many other medications, but there are a few important exceptions that require careful monitoring. The most significant interaction is with the blood thinner warfarin (Coumadin), as Levocarnitine can increase its effects and raise the risk of bleeding. It also interacts with certain anti-seizure medications like valproic acid, which can deplete carnitine levels, often requiring Levocarnitine as a protective measure. Some antibiotics, specifically those containing pivalate, can also lower carnitine levels in the body. Because it affects how your body uses sugar, it might also influence the effectiveness of diabetes medications. Always provide your doctor and pharmacist with a complete list of all prescription drugs, over-the-counter medicines, and herbal supplements you are using to prevent unwanted interactions.
Yes, Levocarnitine is available as a generic medication in several forms, including oral tablets and oral solutions. The generic versions are bioequivalent to the brand-name version, Carnitor, meaning they contain the same active ingredient and work the same way in the body. Generic Levocarnitine is typically more cost-effective and is widely covered by most insurance plans. When picking up your prescription, you may receive the generic form unless your doctor has specifically requested the brand name. It is important to ensure that you are receiving 'Levocarnitine' (the L-isomer) and not a supplement labeled as 'D,L-carnitine,' as the D-isomer can be harmful. Always check with your pharmacist to confirm the quality and source of your medication.
Other drugs with the same active ingredient (Levocarnitine)
> Warning: Stop taking Levocarnitine and call your doctor immediately if you experience any of these:
With prolonged use, the most significant concern is the maintenance of electrolyte balance. Because Levocarnitine facilitates the removal of organic acids, it can indirectly affect the body's acid-base balance. Long-term studies have generally shown Levocarnitine to be safe when used for years in patients with genetic deficiencies, provided that blood levels are monitored to prevent over-supplementation. There is some emerging research into the role of TMAO (the metabolite) in cardiovascular health, but currently, the benefits of treating a confirmed carnitine deficiency far outweigh these theoretical long-term risks.
No FDA black box warnings currently exist for Levocarnitine. It is considered a relatively safe medication with a well-established safety profile, particularly for its life-saving indications in metabolic disease.
Report any unusual symptoms to your healthcare provider. Monitoring of plasma carnitine levels and routine blood chemistry is standard practice during long-term therapy.
Effective therapy requires regular laboratory testing:
Levocarnitine generally does not cause significant sedation or cognitive impairment. However, because dizziness and headaches are possible side effects, patients should observe how they react to the medication before driving or operating heavy machinery.
There are no known direct interactions between Levocarnitine and alcohol. However, alcohol can interfere with liver function and general metabolism, which may complicate the management of the underlying carnitine deficiency. It is best to limit alcohol consumption while on this therapy.
In patients with primary carnitine deficiency, Levocarnitine is a lifelong therapy. Stopping the medication suddenly can lead to a rapid drop in carnitine levels, resulting in muscle breakdown (rhabdomyolysis), hypoglycemia, and potentially fatal heart rhythm issues. Never stop taking Levocarnitine without a tapering plan or alternative treatment strategy provided by your doctor.
> Important: Discuss all your medical conditions, especially any history of kidney disease or seizures, with your healthcare provider before starting Levocarnitine.
Levocarnitine does not typically interfere with standard automated laboratory tests (like basic metabolic panels). However, it will obviously increase the measured levels of carnitine in the blood, which is the intended therapeutic goal. It may also slightly alter the results of tests measuring fatty acid oxidation profiles.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even 'natural' supplements can change how your body processes Levocarnitine.
There is no documented cross-sensitivity between Levocarnitine and other common drug classes (like penicillins or sulfonamides). However, patients sensitive to other amino acid supplements should be monitored for initial reactions.
> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and neurological history, before prescribing Levocarnitine. Ensure you disclose all prior allergic reactions to medications.
Levocarnitine is safe and effective for use in children, including neonates. It is a vital treatment for infants born with genetic metabolic defects. The primary concern in children is ensuring accurate weight-based dosing and monitoring for GI side effects that might interfere with nutrition. It is NOT approved for general 'failure to thrive' unless a specific carnitine deficiency is diagnosed.
Elderly patients are more likely to have age-related declines in renal function. Since Levocarnitine and its metabolites are cleared by the kidneys, the risk of side effects (like the fishy odor or GI upset) may be higher. Doctors usually start with the lowest possible dose and monitor kidney function (Creatinine Clearance) closely.
No specific studies have been conducted in patients with liver impairment. However, since the liver is responsible for carnitine synthesis, these patients may have lower baseline levels. Monitoring of free and total carnitine is the best way to guide dosing in this population.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you are planning a pregnancy or have changes in your kidney function.
| Parameter | Value |
|---|---|
| Bioavailability | 15% - 20% (Oral) |
| Protein Binding | Negligible (0%) |
| Half-life | 17.4 hours (Terminal phase) |
| Tmax | 3.3 hours (Oral) |
| Metabolism | Not metabolized by liver; bacterial in gut |
| Excretion | Renal 90% (as carnitine); Fecal (unabsorbed) |
Levocarnitine is classified as a Carnitine Analog and a Nutraceutical/Metabolic Modifier. It is related to other amino acid derivatives but is unique in its specific role in the carnitine shuttle. It is therapeutically distinct from 'L-carnitine' supplements sold in health stores, which may not meet the USP (United States Pharmacopeia) standards for purity and potency required for clinical Levocarnitine products.